45.2k views
4 votes
In europe, manufacturers of new drugs must submit a risk management plan (eu-rmp) with their application for licensing. how might this practice help protect public health.

User Dolbz
by
7.7k points

1 Answer

3 votes
It is a regulatory document summitted to the health deparment each year or when they create new drugs.
User Shanison
by
7.1k points